2271 related articles for article (PubMed ID: 22740085)
1. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
[TBL] [Abstract][Full Text] [Related]
3. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
4. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract][Full Text] [Related]
5. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
7. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
8. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
9. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L; Johansson AC; Roberg K
PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
[TBL] [Abstract][Full Text] [Related]
12. CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma.
Janisiewicz AM; Shin JH; Murillo-Sauca O; Kwok S; Le QT; Kong C; Kaplan MJ; Sunwoo JB
Int Forum Allergy Rhinol; 2012 Nov; 2(6):465-70. PubMed ID: 22887934
[TBL] [Abstract][Full Text] [Related]
13. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
14. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
15. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.
Biddle A; Gammon L; Liang X; Costea DE; Mackenzie IC
EBioMedicine; 2016 Feb; 4():138-45. PubMed ID: 26981578
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
19. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
